Target intelligence / Profile preview

Biofilm dispersal (None)

Target
None
Molecular classification
Physiological Process, Therapeutic Strategy
01

Overview

Biofilm dispersal is a regulated biological process that serves as the final stage of the biofilm life cycle, where sessile bacteria transition back to a motile, planktonic state to colonize new environments. This process is triggered by various environmental cues, such as nutrient fluctuations or oxygen levels, and is largely governed by intracellular signaling molecules like cyclic-di-GMP (c-di-GMP). While not a single molecule or receptor, biofilm dispersal is a critical therapeutic strategy because biofilms confer up to a 1,000-fold increase in antibiotic tolerance compared to planktonic cells. Drugs targeting this process typically act by degrading the protective extracellular polymeric substance (EPS) matrix—using enzymes like Dornase alfa or Dispersin B—or by delivering low-dose signaling molecules like nitric oxide to trigger active bacterial exit. By forcing bacteria out of the protective biofilm structure, these agents restore the efficacy of conventional antibiotics and the host immune response.

Other names
Biofilm detachmentBiofilm dissolutionBiofilm dispersionSessile-to-planktonic transition
02

Mechanism of action

Induction of the transition from a sessile biofilm state to a free-swimming planktonic state by degrading the extracellular polymeric substance (EPS) matrix or modulating intracellular signaling pathways (e.g., decreasing c-di-GMP levels).

03

Biological functions

Bacterial detachmentPhenotypic switchingExtracellular matrix degradationQuorum sensing regulationColonization of new niches
04

Disease associations

Chronic infectionCystic fibrosisCatheter-associated urinary tract infectionEndocarditisPeriodontitisMedical device-related infection
05

Safety considerations

Risk of septicemia due to massive release of bacteria into the bloodstreamPotential for secondary infection sitesInflammatory response to released bacterial endotoxins
06

Interacting drugs

Dornase alfa

4 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA) levelsc-di-GMP concentrationPlanktonic bacterial cell countAlginate concentration

Beyond the preview

Go deeper on Biofilm dispersal (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biofilm dispersal (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call